AB BioTechnologies, a contract service provider based in Bloomington, Indiana, has expanded its services to include preclinical manufacturing at its Bloomington facility, allowing it to execute projects on both the small-molecule and large-molecule scale and projects involving liquid, lyophilized, vial, or syringe delivery formulations.

The company will perform GLP (good laboratory practice) manufacturing at its existing facility. Implementation of processes is underway, and a third-party audit is expected to be completed by the end of the third quarter of 2016.

Source: AB BioTechnologies